Since the cytochrome P450 (CYP) enzyme is involved in the oxidative metabolism of estrogen, the gene polymorphism related to estrogen biosynthesis and metabolism is potential risk factor for estrogen receptor-positive malignant tumors [20]. Here, ESR1 is linked to cancer.